Page last updated: 2024-10-27

fluorouracil and Puerperal Disorders

fluorouracil has been researched along with Puerperal Disorders in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Puerperal Disorders: Disorders or diseases associated with PUERPERIUM, the six-to-eight-week period immediately after PARTURITION in humans.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pride, GL1

Other Studies

1 other study available for fluorouracil and Puerperal Disorders

ArticleYear
Treatment of large lower genital tract condylomata acuminata with topical 5-fluorouracil.
    The Journal of reproductive medicine, 1990, Volume: 35, Issue:4

    Topics: Administration, Topical; Adolescent; Adult; Condylomata Acuminata; Female; Fluorouracil; Genital Neo

1990